Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02422589
Title A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors
Recruitment Completed
Gender
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
Karmanos Cancer Institute Oncology Department Detroit Michigan 48201 United States Details
Henry Ford Hospital SC Detroit Michigan 48202-2689 United States Details
Cancer Therapy & Research Center UT Health Science Center SC-4 San Antonio Texas 78229 United States Details
Novartis Investigative Site Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Padova PD 35100 Italy Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field